|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2003-9-1
|
|
pubmed:abstractText |
H. pylori eradication is usually performed with three or four drugs for at least seven days. Recently four reports have shown a cure rate of approximately 90% using a four-day quadruple therapy. The objectives of this prospective study were: 1) to evaluate the efficacy of pantoprazole-based quadruple therapy, and 2) to compare the efficacy and tolerability of four-day with seven-day quadruple therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/2-Pyridinylmethylsulfinylbenzimidazo...,
http://linkedlifedata.com/resource/pubmed/chemical/Antacids,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Ulcer Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Benzimidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Bismuth,
http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole,
http://linkedlifedata.com/resource/pubmed/chemical/Omeprazole,
http://linkedlifedata.com/resource/pubmed/chemical/Sulfoxides,
http://linkedlifedata.com/resource/pubmed/chemical/Tetracycline,
http://linkedlifedata.com/resource/pubmed/chemical/pantoprazole
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0300-2977
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
61
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
218-22
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12956102-2-Pyridinylmethylsulfinylbenzimidazoles,
pubmed-meshheading:12956102-Adult,
pubmed-meshheading:12956102-Aged,
pubmed-meshheading:12956102-Aged, 80 and over,
pubmed-meshheading:12956102-Antacids,
pubmed-meshheading:12956102-Anti-Bacterial Agents,
pubmed-meshheading:12956102-Anti-Ulcer Agents,
pubmed-meshheading:12956102-Benzimidazoles,
pubmed-meshheading:12956102-Bismuth,
pubmed-meshheading:12956102-Drug Administration Schedule,
pubmed-meshheading:12956102-Drug Therapy, Combination,
pubmed-meshheading:12956102-Female,
pubmed-meshheading:12956102-Helicobacter Infections,
pubmed-meshheading:12956102-Helicobacter pylori,
pubmed-meshheading:12956102-Humans,
pubmed-meshheading:12956102-Male,
pubmed-meshheading:12956102-Metronidazole,
pubmed-meshheading:12956102-Middle Aged,
pubmed-meshheading:12956102-Omeprazole,
pubmed-meshheading:12956102-Sulfoxides,
pubmed-meshheading:12956102-Tetracycline
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Comparison of four-day and seven-day pantoprazole-based quadruple therapy as a routine treatment for Helicobacter pylori infection.
|
|
pubmed:affiliation |
Department of Internal Medicine, Slingeland Hospital, Doetinchem, the Netherlands. s.de.boer@slingeland.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Research Support, Non-U.S. Gov't
|
